Targeting a Key Driver of Cancer
The Ras protein is one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Scientists are getting close to changing that.
University of California San Francisco
Give to UCSFThe Ras protein is one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Scientists are getting close to changing that.
Parents who have a child with autism spectrum disorder (ASD) are about one third less likely to have more children than families without an affected child, according to a study led by a UC San Francisco researcher.
In the most comprehensive study of the Mexican population to date, researchers from UCSF and Stanford University, along with Mexico’s National Institute of Genomic Medicine, have identified tremendous genetic diversity.
New genomic research led by UCSF scientists reveals that two common gene variants that lead to longer telomeres also significantly increase the risk of developing the deadly brain cancers known as gliomas.
Research led by a UCSF investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
UCSF has been selected to join a national “dream team” on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.